Ropes Wealth Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-342
Closed -$61K 628
2020
Q1
$61K Buy
342
+11
+3% +$2.07K 0.02% 268
2019
Q4
$63K Hold
331
0.01% 317
2019
Q3
$56K Hold
331
0.01% 330
2019
Q2
$55K Hold
331
0.01% 328
2019
Q1
$48K Hold
331
0.01% 337
2018
Q4
$44K Sell
331
-100
-23% -$16.4K 0.01% 320
2018
Q3
$82K Buy
431
+27
+7% +$4.96K 0.02% 293
2018
Q2
$67K Hold
404
0.02% 322
2018
Q1
$68K Sell
404
-30
-7% -$5.03K 0.02% 303
2017
Q4
$71K Sell
434
-201
-32% -$36.1K 0.02% 311
2017
Q3
$130K Buy
635
+30
+5% +$6.98K 0.04% 246
2017
Q2
$147K Buy
605
+30
+5% +$7.05K 0.04% 237
2017
Q1
$137K Buy
575
+136
+31% +$31.7K 0.04% 243
2016
Q4
$92K Sell
439
-453
-51% -$93.8K 0.03% 267
2016
Q3
$205K Sell
892
-97
-10% -$23.7K 0.07% 193
2016
Q2
$229K Buy
989
+492
+99% +$113K 0.08% 175
2016
Q1
$133K Sell
497
-197
-28% -$56.4K 0.06% 173
2015
Q4
$217K Buy
694
+262
+61% +$78K 0.1% 153
2015
Q3
$117K Buy
432
+28
+7% +$8.6K 0.06% 177
2015
Q2
$123K Sell
404
-178
-31% -$53.1K 0.07% 150
2015
Q1
$173K Buy
+582
New +$166K 0.09% 134

Other funds holding AGN

Ropes Wealth Advisors's AGN Position: Q2 2020 in Review

Ropes Wealth Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 342 shares — an estimated $61K sold.

Ropes Wealth Advisors first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $229K in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ropes Wealth Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ropes Wealth Advisors sold 342 Allergan plc shares in Q2 2020, an estimated $61K.
  • Ropes Wealth Advisors first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Ropes Wealth Advisors's Allergan plc position peaked at $229K in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ropes Wealth Advisors's 13F filing for Q2 2020, filed 20 Jul 2020.